AMAG Pharmaceuticals, Inc. announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience and extensive leadership skills to AMAG. He joins AMAG from Genzyme Corporation, where he spent the past 12 years in various commercial roles in their renal division, most recently as the division's vice president and general manager.

Since joining Genzyme in 2000, Mr. Madison developed extensive commercial and general management expertise as he progressed into roles of increasing responsibilities and leadership, culminating in his most recent role as vice president and general manager for the renal division. In this role, Mr. Madison led a global organization with three marketed products in 76 countries and drove top-line growth, with combined revenues exceeding $1 billion. Mr. Madison's prior experience in the division includes serving as vice president and general manager of the U.S. business; vice president of U.S. sales; and vice president of U.S. marketing where he led all pre-launch preparation for Renvela.

During his tenure with Genzyme, Mr. Madison also had roles in sales management, training, and managed markets and reimbursement.